News & Press Releases 2024

To the Organ Transplantation Community, It’s hard to believe that the holiday season is upon us again. Most of us probably take this time to reflect on the past year: achievements, setbacks, ups and downs. Then we all look ahead to what will hopefully be a healthy, joyous and potentially more productive new year. We at Bridge to Life are no different…

We are excited to report that 2024 has indeed been a year of profound accomplishments for Bridge to Life. And all our achievements have been in the service of the transplantation community.

Let’s start with our “new” news, then work back through the year.

Bridge to Life Ltd., a leader in organ preservation solutions and perfusion technology, has acquired the VitaSmart Hypothermic Oxygenated Machine Perfusion System from Medica S.p.A.. The agreement also includes exclusive global trademark rights and the ability to register the VitaSmart name worldwide…

This week, Bridge to Life celebrates a special milestone-the one-year anniversary of our office in Duluth, Georgia! This occasion marks not only a year of growth in expanding our footprint, but also the continued dedication of our entire team to advance the field of organ preservation and improve transplant outcomes…

Bridge to Life Ltd., a leading provider of organ preservation solutions and organ perfusion equipment, has announced that more than 5,000¹ liver perfusions worldwide have been successfully performed using Hypothermic Oxygenated Perfusion (HOPE) in combination with its VitaSmart2 Hypothermic Machine Perfusion…

In previous posts, I have shared my perspective on topics of interest to our transplantation community. Through these communications, I hope that you have a better sense of how committed Bridge to Life is to enhancing the preservation of organs awaiting transplantation, improving access to organs and reducing post-surgical complications. While you may know Bridge to Life as innovators in transplantation products, services, technology and research…

Bridge to Life Ltd, a global market leader in organ preservation solutions and machine perfusion technologies, and ULS Coimbra, one of the largest hospitals in Portugal with a legacy of innovation in organ transplantation, today announced a collaboration to further improve the preservation of livers…

Bridge to Life Ltd, a global market leader in organ preservation solutions and machine perfusion technologies, and ULS Coimbra, one of the largest hospitals in Portugal with a legacy of innovation in organ transplantation, today announced a collaboration to further improve the preservation of livers…

The analysis is being presented this week at the American College of Surgeons Clinical Congress 2024 (ACS 2024) in San Francisco, California, October 19-22, 2024 Chicago, October 21, 2024   An analysis of 100 cases of liver transplantations at a Portuguese Transplant Center demonstrates that the use of Hypothermic Oxygenated PErfusion (HOPE) has the potential to lower the incidence of complications and maximizes the use of donor organs with extended criteria…

Dear Transplant Community,
We understand many of you have concerns regarding the recent challenges facing the U.S. medical device industry, including the impacts of Hurricane Helene and the Dock Workers’ Strike.
We’re pleased to inform you that Bridge to Life’s supply chain remains unaffected by these events.

The three clinical trials are discussed in oral and mini-oral presentations at the 30th International Congress of The Transplantation Society (TTS 2024) in Istanbul, Turkey, September 22-25, 2024 Chicago, September 23, 2024   Three Italian studies on HOPE (Hypothermic Oxygenated Perfusion) in liver transplantation are being presented this week at the 2024 30th Annual Meeting of the International Congress of The Transplantation Society (TTS 2024) in Istanbul, Turkey…

Mainstream media has once again reported on news relevant to the transplantation community but seems to have left out, perhaps unintentionally, a critical aspect of the story. Recently, NPR covered an organ retrieval procedure that remains scarcely used in the U.S. In the article and radio piece titled “Doctors Try a Controversial Technique to Reduce the Transplant Organ Shortage,” NPR discussed the use of normothermic regional…

Chicago, September 3, 2024 Bridge to Life Ltd, a renowned market leader in organ preservation solutions, today announced acceptance of three abstracts based on data from Italian clinical trials using HOPE (Hypothermic Oxygenated Perfusion), including an oral and two mini-oral for presentation, at the 2024 30th annual meeting of the International…

To the Organ Transplantation Community,
We are just wrapping up the trifecta of Spring 2024 national and global congresses for the transplantation community: the European Liver and Intestine Transplant Association (ELITA) Summit 2024, organized by European Society for Organ Transplantation (ESOT) in April; the 2024 Annual Congress of the International Liver Transplantation Society (ILTS) in May; and now the just-completed American Transplant Congress (ATC), the Joint Annual Meeting of the American Society of Transplant Surgeons (ASTS) and the American Society of Transplantation…

Chicago, June 4, 2024 – Bridge to Life Ltd, a leading provider of organ preservation solutions, has announced the latest findings from the Bridge to HOPE clinical trial, utilizing the VitaSmart Machine Perfusion System. The trial evaluates the safety and efficacy of static cold storage (SCS), the current standard for ex-vivo organ preservation, compared to SCS followed by hypothermic…

Chicago, May 8, 2024   Bridge to Life Ltd, a renowned market leader in organ preservation solutions, today announced acceptance of four abstracts based on data from its U.S. pivotal clinical trial on HOPE using the VitaSmart Liver Machine, including a late-breaker, for presentation at the 2024 annual meeting of the American Transplant Congress (ATC). The conference is scheduled to take place in Philadelphia, PA from June 1-5, 2024…

Houston, May 2, 2024 Philipp Dutkowski leads the ILTS 2024 Knowledge Hub discussion on the treatment and assessment of liver grafts during hypothermic oxygenated perfusion…

Results of late-breaker Cochrane review and meta-analysis confirmed significant improvement in several parameters with HOPE compared to static cold storage and normothermic machine perfusion (NMP). While both technologies proved to be superior to SCS, there is no good evidence that NMP has the same benefits over SCS in terms of these clinically relevant…

To the Organ Transplantation Community,
In my last post , I referenced that through hypothermic oxygenated perfusion (HOPE), organs awaiting transplantation are cooled to temperatures typically ranging between 4 and 10°C, significantly reducing their metabolic rate to about 10% of normal. This oxygen-rich perfusion revitalizes the mitochondria, the powerhouse and energy reservoir of the cells. Essentially, this process primes the cells before transplantation…

Portuguese study confirms use of HOPE provides demonstrably improved liver graft utilization with reduced rates of non-anastomatic biliary stricture (NAS); Italian study demonstrates increasing experience in managing DCD (donation after circulatory determination of death) results in greater utilization of more marginal donors and transplantation in…

To the Organ Transplantation Community,
As April unfolds, National Donate Life Month comes into focus, illuminating the urgent importance of organ, eye, and tissue donation. This dedicated month honors the incredible donors and their families whose selflessness transforms lives through organ transplants. An outcome of this awareness is the increased media attention on transplantation…

Bridge to Life Ltd, a renowned market leader in organ preservation solutions, today announced the presentation of five accepted abstracts, including a late-breaker, at the 2024 International Congress of the International Liver Transplantation Society (ILTS). The conference is scheduled to take place in Houston, Texas, from May 1-4…

Bridge to Life Ltd, a renowned market leader in organ preservation solutions, today announced the presentation of two accepted abstracts at the 2024 ELITA Summit under the auspices of The European Society for Transplantation. The conference is scheduled to take place in Madrid, Spain, from April 18-20, 2024. Abstracts to be presented: 100 Hypothermic Oxygenated Perfusion liver transplants in a Portuguese Centre, Júlio Constantino, MD et a…

To the Organ Transplantation Community,
In keeping with the Bridge to Life mission and philosophy of offering premier organ transplantation products with a strong focus on product quality, innovation and accessibility in partnership with leading Transplant Centers and Organ Procurement Organizations (OPO) globally, I am excited to introduce here a periodic blog where I will update our community on Bridge to Life…

Bridge to Life Ltd, a leading provider of organ preservation solutions, today announces the return of EasiSlush™ to the US market, effective immediately. With its unmatched ease of use, high quality and portability, EasiSlush has become the preferred choice for organ transplant professionals who are responsible for transporting life-giving organs from donors to recipients under critical timelines.

Bridge to Life Ltd, a renowned market leader in cold flush organ preservation solutions, is proud to announce its recent certification for ISO 13485:2016. This achievement further solidifies the company’s commitment to maintaining exceptional standards of quality and safety in its premier products, including Belzer UW, EasiSlush^® and VitaSmart™ Machine Perfusion System (Europe).